Song, M., Liu, X., Liu, K., Zhao, R., Huang, H., Shi, Y., . . . Lee, M. (2018). Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient derived xenografts in vivo. Mol Cancer Ther.
Stile di citazione ChicagoSong, Mengqiu, et al. "Targeting AKT With Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma in Vitro and Patient Derived Xenografts in Vivo." Mol Cancer Ther 2018.
Citazione MLASong, Mengqiu, et al. "Targeting AKT With Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma in Vitro and Patient Derived Xenografts in Vivo." Mol Cancer Ther 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.